Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,463,000 | 14,487,000 | 17,604,000 | 14,332,000 | 12,671,000 |
| Marketable Securities | 19,925,000 | 17,121,000 | 13,397,000 | 10,974,000 | 11,948,000 |
| Receivables | 15,594,000 | 15,283,000 | 14,911,000 | 14,871,000 | 14,938,000 |
| Inventories | 10,990,000 | 10,387,000 | 10,387,000 | 10,100,000 | 9,952,000 |
| TOTAL | $60,424,000 | $60,979,000 | $59,889,000 | $53,769,000 | $52,533,000 |
| Non-Current Assets | |||||
| PPE Net | 18,701,000 | 18,962,000 | 18,478,000 | 18,632,000 | 18,367,000 |
| Intangibles | 79,355,000 | 81,638,000 | 83,345,000 | 86,063,000 | 86,798,000 |
| Other Non-Current Assets | 19,875,000 | 20,439,000 | 17,516,000 | 17,976,000 | 14,859,000 |
| TOTAL | $117,931,000 | $121,039,000 | $119,339,000 | $122,671,000 | $120,024,000 |
| Total Assets | $178,355,000 | $182,018,000 | $179,228,000 | $176,440,000 | $172,557,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,309,000 | 11,055,000 | 8,961,000 | 8,704,000 | 8,503,000 |
| Accrued Expenses | 28,076,000 | 29,293,000 | 29,641,000 | 25,644,000 | 27,202,000 |
| TOTAL | $43,390,000 | $45,226,000 | $44,561,000 | $38,721,000 | $40,932,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,851,000 | 29,985,000 | 30,130,000 | 30,310,000 | 30,263,000 |
| aiOther Non-Current Liabilities | 24,981,000 | 25,297,000 | 27,118,000 | 28,813,000 | 29,021,000 |
| TOTAL | $60,256,000 | $62,769,000 | $64,395,000 | $68,139,000 | $65,791,000 |
| Total Liabilities | $103,646,000 | $107,995,000 | $108,956,000 | $106,860,000 | $106,723,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,631,402 | 2,629,268 | 2,632,597 | 2,632,482 | 2,633,396 |
| Common Shares | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 |
| Retained earnings | 124,380,000 | 123,060,000 | 121,092,000 | 120,154,000 | 116,508,000 |
| Other shareholders' equity | -13,757,000 | -13,058,000 | -15,415,000 | -15,100,000 | -15,328,000 |
| TOTAL | $74,709,000 | $74,023,000 | $70,272,000 | $69,580,000 | $65,834,000 |
| Total Liabilities And Equity | $178,355,000 | $182,018,000 | $179,228,000 | $176,440,000 | $172,557,000 |